http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013092783-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1224e3c07b7cc5684ee81d9e1e5ee15c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0452 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0438 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-04 |
| filingDate | 2012-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76f7921e42522d26f5934de3f4c5a763 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8daafa877841965c6b3d2b8b0ff19abc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04be0e26e49d2e28a8aa508f5437768b |
| publicationDate | 2013-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2013092783-A1 |
| titleOfInvention | Stabilization of x-ray diagnostic composition |
| abstract | The invention relates to a composition comprising a non-ionic X-ray contrast agent in a pharmaceutically acceptable carrier, and particularly to a supersaturated X-ray composition comprising X-ray contrast agents with a high dissolution temperature in water. Particularly, the invention provides such composition which is stable, and wherein crystallisation during storage is avoided. In a preferred aspect the X-ray contrast agent is Ioforminol and the composition includes a nucleation-and growth inhibitor. The invention further relates to a process for the preparation of such stable diagnostic X-ray composition. |
| priorityDate | 2011-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 103.